Thromb Haemost 1974; 32(02/03): 277-283
DOI: 10.1055/s-0038-1647698
Original Article
Schattauer GmbH

The Use of the Fibrinogen Turnover and the Isotope Scanning of the Legs for the Diagnosis of Venous Thrombosis in Non Surgical Patients

G. J. H den Ottolander
1   Department of Internal Medicine and Laboratory of Endocrinological Chemistry, Municipal Hospital Bergweg, Rotterdam, The Netherlands
,
A. P. C van der Maas
1   Department of Internal Medicine and Laboratory of Endocrinological Chemistry, Municipal Hospital Bergweg, Rotterdam, The Netherlands
,
W Schopman
1   Department of Internal Medicine and Laboratory of Endocrinological Chemistry, Municipal Hospital Bergweg, Rotterdam, The Netherlands
› Author Affiliations
Further Information

Publication History

Received 15 May 1974

Accepted after resubmission 22 May 1974

Publication Date:
30 June 2018 (online)

Summary

In 2 groups of non surgical patients with venous thrombosis (V. T.) the fibrinogen turnover rate was determined in addition to scanning of the legs.

In the first group of 13 patients with clinical signs of V. T. the Tx/2 of 131I-fibrinogen was shorter than in a normal group. In the second group of 10 patients with V. T., diagnosed only by local scanning of the legs using 125I-fibrinogen, the T72 was also shortened.

Because of the longer half life time of the 125I-label, observations can be carried out during a period of 20 days, so that 125I-fibrinogen is preferable to 131I-fibrinogen. Of 33 elderly patients treated for congestive heart failure a positive leg scan was observed in 15. Treatment with intravenously injected heparin immediately interferes with further accumulation of radioactivity and corrects the shortened TVa to normal values, in contrast to treatment with oral anticoagulants.

 
  • References

  • 1 Collen D, Tijtgat G. N, Claeys H, Piessens R. 1972; Fibrinogen turnover in physiological conditions in Humans. British Journal of Haematology 22: 681.
  • 2 Hart H. C. 1966 The biological half life of 1311-fibrinogen. Academical Thesis. Utrecht, The Netherlands..
  • 3 Jeyasingh K, Maurer B, Rosengarten D. S, Verma T. R. 1970; Decline of blood activity of 125I-fibrinogen in venous thrombosis. Lancet 12: 294.
  • 4 Regoeczi E. 1971; Iodine-labelled fibrinogen: A review. British Journal of Haematology 20: 649.
  • 5 Takeda Y. 1966; Studies of the metabolism and distribution of fibrinogen in healthy men with autologous 125I-labelled fibrinogen Journal of Clinical Investigations. 45: 103.
  • 6 Teulings F. A. G, Biggs G. J. 1970; Study of electrolytic labeling of fibrinogen with 131Iodine by sephadex G-10 gel infiltration. Clinica Chimica Acta 27: 57.
  • 7 van der Maas A. P. C, Teulings F. A. G, den Ottolander G. J. H. 1971; The use of labelled fibrinogen in the diagnosis of venous thrombosis. Thrombosis et Diathesis Haemorrhagica 26: 1.
  • 8 van der Maas A. P. C, Teulings F. A. G, Schopman W, den Ottolander G. J. H. 1972; The influence of acenocoumarole on the fibrinogen turnover in normal subjects, venous thrombosis and congestive heart failure. Thrombosis et Diathesis Haemorrhagica 28: 496.